Belite Bio BLTE
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$13.90M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 56.2% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 2.77% to 3.43% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +62,842 | 0.2% |
| Alberta Investment Management Corporation | Government Pension Fund | 2026/Q3 | +24,000 | 0.1% |
| Barclays PLC | Public Company | 2026/Q3 | +23,252 | 0.1% |
| Patient Square Capital, LP | VC/PE Fund | 2026/Q3 | +21,700 | 0.3% |
| Maverick Capital, Ltd. | Hedge Fund | 2026/Q3 | +396,311 | 1.0% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +250,000 | 0.6% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +184,160 | 0.5% |
| Bank of America Corporation | Public Company | 2026/Q3 | +119,885 | 0.3% |
| Paradigm Biocapital Advisors LP | Hedge Fund | 2026/Q3 | +118,093 | 3.1% |
| Affinity Asset Advisors, LLC | Hedge Fund | 2026/Q3 | +100,000 | 0.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +75,589 | 0.6% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +60,679 | 0.4% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +53,579 | 0.2% |
| Deerfield Management Company, L.P. | Hedge Fund | 2026/Q3 | +53,186 | 0.9% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +51,186 | 0.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 28 Oct 2026 | Hao-Yuan Chuang | Chief Financial Officer | Other Acquisition | +5,000 | – | 210,264 |
| 28 Oct 2026 | Yu-Hsin Lin | Chairman of the Board of Directors & CEO | Other Acquisition | +5,000 | – | 187,949 |
| 30 Sep 2026 | Hendrik Scholl | Chief Medical Officer | Private Disposition | -500 | $170.02 | 14,500 |
| 23 Sep 2026 | Wan-Shan Chen | Director | Derivative Exercise and Retained | +13,796 | $0.44 | 37,259 |
| 7 Sep 2026 | Hao-Yuan Chuang | Chief Financial Officer | Automatic Disposition | -67,395 | $198.05 | 26,038 |
| 7 Sep 2026 | Yu-Hsin Lin | Chairman of the Board of Directors & CEO | Automatic Disposition | -100,435 | $198.09 | 70,134 |
| 11 Aug 2026 | Hao-Yuan Chuang | Chief Financial Officer | Automatic Disposition | -367 | $180.57 | 93,433 |
| 11 Aug 2026 | Yu-Hsin Lin | Chairman of the Board of Directors & CEO | Automatic Disposition | -365 | $180.57 | 170,569 |
| 17 Jun 2026 | Hendrik Scholl | Chief Medical Officer | Private Disposition | -10,000 | $147.11 | 15,000 |
| 15 Jun 2026 | Hendrik Scholl | Chief Medical Officer | Private Disposition | -10,000 | $145.02 | 25,000 |
| 6 May 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -666 | $155.25 | – |
| 5 May 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $156.00 | 666 |
| 4 May 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $158.11 | 1,666 |
| 3 May 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $157.49 | 2,666 |
| 30 Apr 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $160.00 | 3,666 |
| 29 Apr 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $158.15 | 4,666 |
| 28 Apr 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $158.19 | 5,666 |
| 27 Apr 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $162.14 | 6,666 |
| 26 Apr 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $164.07 | 7,666 |
| 23 Apr 2026 | Nathan Mata | Chief Scientific Officer | Automatic Disposition | -1,000 | $162.53 | 8,666 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 1,380,466 | 3.4% | 10.0 |
| 15 Oct 2026 | 1,267,440 | 3.1% | 7.1 |
| 30 Sep 2026 | 1,057,536 | 2.6% | 7.3 |
| 15 Sep 2026 | 1,050,466 | 2.6% | 3.8 |
| 31 Aug 2026 | 1,049,817 | 2.6% | 7.4 |
| 14 Aug 2026 | 1,116,380 | 2.8% | 5.8 |
No comments yet — be the first to weigh in on BLTE.
Sign in to join the discussion.